Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflavone extract (Phytosoya) for endometrial and breast safety in postmenopausal women
NCT00235924Phase 3Unknown
- Sponsor
- Arkopharma
- Start
- Jun 2004
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of Hizofito in climacteric syndrome, sponsored by Arkopharma. Primary endpoint: Endometrial innocuity (endometrial biopsy result) at 3 years. Status: unknown.
02
Drugs
Hizofito
03
Conditions
climacteric syndrome
Beyond the preview
Go deeper on NCT00235924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235924.